drugset
drugset / Trial / NCT01160302

Curcumin Biomarker Trial in Head and Neck Cancer

NCT01160302 ↗

Phase 0 Completed 33 enrolled Louisiana State University Health Sciences Center Shreveport Feist-Weiller Cancer Center at Louisiana State University Health Sciences · collabNational Cancer Institute (NCI) · collab
NaSingle-groupOpen-labelBasic science

Summary

There is considerable evidence that turmeric consumption may have a protective effect against cancer progression. The purpose of this study is to examine the short-term effects of supplementation with a turmeric extract, Curcumin C3 Complex®, on biomarkers of head and neck squamous cell carcinoma (HNSCC).

Timeline

Start
2010-06
Primary completion
2016-01
Completion
2016-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Curcumin Small molecule 4 g —

Indications

head and neck squamous cell carcinoma